Triphenylphosphonium‐conjugated poly (ε‐caprolactone)‐based self‐assembled nanostructures as nanosized drugs and drug delivery carriers for mitochondria …

DY Cho, H Cho, K Kwon, M Yu, E Lee… - Advanced Functional …, 2015 - Wiley Online Library
For mitochondria‐targeting delivery, a coupling reaction between poly (ε‐caprolactone) diol
(PCL diol) and 4‐carboxybutyltriphenylphosphonium (4‐carboxybutyl TPP) results in the …

Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment

G Battogtokh, YY Cho, JY Lee, HS Lee… - Frontiers in …, 2018 - frontiersin.org
The mitochondrion is an important intracellular organelle for drug targeting due to its key
roles and functions in cellular proliferation and death. In the last few decades, several …

Reversing chemotherapy resistance by a synergy between lysosomal pH-activated mitochondrial drug delivery and erlotinib-mediated drug efflux inhibition

F Cheng, Q Pan, W Gao, Y Pu, K Luo… - ACS Applied Materials & …, 2021 - ACS Publications
Mitochondrial drug delivery has attracted increasing attention in various mitochondrial
dysfunction-associated disorders such as cancer owing to the important role of energy …

Dual‐Targeting Polymeric Nanocarriers to Deliver ROS‐Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells

L Xi, J Wang, Y Wang, Z Ge - Macromolecular Bioscience, 2021 - Wiley Online Library
Targeting delivery of anticancer drugs that can interact with DNA into mitochondria of cancer
cells has been demonstrated to be an effective method to combat drug resistance. In this …

Charge conversion polymer–liposome complexes to overcome the limitations of cationic liposomes in mitochondrial-targeting drug delivery

PW Shueng, LY Yu, HH Hou, HC Chiu… - International Journal of …, 2022 - mdpi.com
Mitochondrial-targeting therapy is considered an important strategy for cancer treatment.(3-
Carboxypropyl) triphenyl phosphonium (CTPP) is one of the candidate molecules that can …

Induction of mitochondrial apoptosis for cancer therapy via dual-targeted cascade-responsive multifunctional micelles

G Wei, Y Wang, X Huang, G Yang, J Zhao… - Journal of materials …, 2018 - pubs.rsc.org
Herein, we present a prodrug-loaded multifunctional polymer micelle with
hyaluronidase/redox/light multilevel responses and with cell membrane/mitochondrion-dual …

[引用][C] ROS-responsive mitochondria-targeting blended nanoparticles for chemo-and photodynamic synergistic therapy for lung cancer

C Yue, Y Yang, C Zhang, G Alfranca, D Cui - Journal of Controlled Release, 2017 - Elsevier

Combination of mitochondria impairment and inflammation blockade to combat metastasis

X Yi, Y Yan, L Li, R Zhou, X Shen, Y Huang - Journal of Controlled Release, 2022 - Elsevier
Targeted induction of mitochondria impairment has emerged as a promising strategy for anti-
metastasis therapy. However, problems such as limited mitochondria targeting efficiency …

[HTML][HTML] ROS-responsive mitochondria-targeting blended nanoparticles: chemo-and photodynamic synergistic therapy for lung cancer with on-demand drug release …

C Yue, Y Yang, C Zhang, G Alfranca, S Cheng, L Ma… - Theranostics, 2016 - ncbi.nlm.nih.gov
Mitochondria in cancer cells maintain a more negative membrane potential than normal
cells. Mitochondria are the primary source of cellular reactive oxygen species (ROS), which …

[HTML][HTML] Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting

M Zhou, L Li, L Li, X Lin, F Wang, Q Li… - Acta Pharmaceutica Sinica …, 2019 - Elsevier
Multidrug resistance (MDR) has been considered as a huge challenge to the effective
chemotherapy. Therefore, it is necessary to develop new strategies to effectively overcome …